Roth wrote that the hospital would take “corrective actions” against the two physicians — Dr. George Grammatopoulos and Dr.

New insights into a "friendly virus" that could pave the way for cutting-edge treatments for the potentially fatal superbug C ...

Bacteriophages are viruses that selectively target and kill bacteria. They are abundant, commonly occurring natural entities ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

Known as phage therapy, it uses viruses to kill harmful bacteria in difficult-to-treat infections. Read more at ...

BiomX announced a series of financings with total gross proceeds of approximately $12 million to support completion of Phase 2b ...

Phage therapy has recently garnered significant attention as an alternative or adjunctive approach to conventional antibiotic treatments, especially against ...

Fourth Quarter 2024 and Recent Developments: The Phase 2 Tailwind study represents the second successful clinical trial for AP-PA02, Armata's lead pulmonary candidate, which was first evaluated in ...

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company ...

Fairburn explains that in the absence of an active anti-phage defence, viral infections inhibit bacterial growth and cause a ...

University of Toronto researchers have discovered nine new genes used by bacteria to protect themselves against ...

University of Toronto researchers have discovered nine new genes used by bacteria to protect themselves against phages - ...